Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5274231
Max Phase: Preclinical
Molecular Formula: C17H15NS
Molecular Weight: 265.38
Associated Items:
ID: ALA5274231
Max Phase: Preclinical
Molecular Formula: C17H15NS
Molecular Weight: 265.38
Associated Items:
Canonical SMILES: c1ccc(-c2c(-c3cccs3)cn3c2CCC3)cc1
Standard InChI: InChI=1S/C17H15NS/c1-2-6-13(7-3-1)17-14(16-9-5-11-19-16)12-18-10-4-8-15(17)18/h1-3,5-7,9,11-12H,4,8,10H2
Standard InChI Key: PRFLTDYOAMOLAD-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 265.38 | Molecular Weight (Monoisotopic): 265.0925 | AlogP: 4.83 | #Rotatable Bonds: 2 |
Polar Surface Area: 4.93 | Molecular Species: | HBA: 2 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 1 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 4.60 | CX LogD: 4.60 |
Aromatic Rings: 3 | Heavy Atoms: 19 | QED Weighted: 0.63 | Np Likeness Score: -1.05 |
1. Gouda AM, Abdelazeem AH.. (2016) An integrated overview on pyrrolizines as potential anti-inflammatory, analgesic and antipyretic agents., 114 [PMID:26994693] [10.1016/j.ejmech.2016.01.055] |
Source(1):